Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Year Exploratory, Observational, Non-Interventional Multicenter Study To Identify Early Markers Of Choroidal Neovascularization In Fellow Eyes Of Patients With Neovascular AMD In One Eye

NCT00902785 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00902785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00902785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Year Exploratory, Observational, Non-Interventional Multicenter Study To Identify Early Markers Of Choroidal Neovascularization In Fellow Eyes Of Patients With Neovascular AMD In One Eye
Lead sponsor
Pfizer
Phase
Observational
Overall status
Terminated
Start date
March 31, 2008
Completion date
May 31, 2010
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration (amd), choroidal neovascularization (cnv), early markers